Group One Trading
NMRA icon

Group One Trading’s Neumora Therapeutics NMRA Stock Holding History

Group One Trading’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95.7K Buy
56,300
+48,400
+613% +$92.1K ﹤0.01% 4900
2026
Q1 		$15.4K Buy
+7,900
New +$20.5K ﹤0.01% 6114
2025
Q4 		– Sell
-28,300
Closed -$51.5K – 8824
2025
Q3 		$51.5K Buy
28,300
+19,800
+233% +$32K ﹤0.01% 5938
2025
Q2 		$6.23K Sell
8,500
-18,700
-69% -$14.2K ﹤0.01% 6990
2025
Q1 		$27.2K Sell
27,200
-10,400
-28% -$17.8K ﹤0.01% 5607
2024
Q4 		$399K Buy
37,600
+37,200
+9,300% +$446K ﹤0.01% 3362
2024
Q3 		$5.28K Buy
+400
New +$4.67K ﹤0.01% 5857

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Group One Trading's NMRA Position: Q2 2026 in Review

Group One Trading reduced its Neumora Therapeutics (NMRA) stake by 3.4% in Q2 2026, selling an estimated $2.99K and leaving 44,471 shares worth $75.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5082.

Group One Trading first reported a position in NMRA in Q3 2024 and has held it in 3 quarters since. The position peaked at $208K in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • Group One Trading held 44,471 shares of Neumora Therapeutics worth $75.6K as of Q2 2026.
  • Group One Trading sold 1,571 Neumora Therapeutics shares in Q2 2026, an estimated $2.99K.
  • Neumora Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5082 holding.
  • Group One Trading first reported a position in Neumora Therapeutics in Q3 2024 and has held it in 3 quarters since.
  • Group One Trading's Neumora Therapeutics position peaked at $208K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.